Bryden et al., 2014), dibromopyridazinediones (Maruani et al., 2015), and a 1,3-bis( p -toluenesulfonyl)propane-based core (Bryant et al., 2015) can accept two reduced cysteines derived from interchain disulfide bonds to afford a rebridged antibody (Fig
They can inhibit the development of endometriotic lesions, inhibit inflammation, and exert anti-angiogenic effects (Man 2012)
This review focuses on GSH/GSSG system-based biomedical and pharmaceutical applications with relevant basic and comprehensive background information
doi: 10.3390/healthcare11131946 [DOI] [PMC free article] [PubMed] [Google Scholar] 2.WHO
The diagnosis of CPT2 deficiency is based on elevated levels of C12- to C18-ACs, specifically increased levels of C16- and C18:1-ACs and reduced levels of free carnitine